NEW YORK (GenomeWeb News) – World Fusion will distribute Ariadne’s products in Japan and will serve as Ariadne’s support center for its MedScan technology and its Pathway Studio product lines under an exclusive agreement, Ariadne said this week.
The company’s Pathway Studio software allows scientists to control “vast amounts of publicly available information and supplements all states of research,” including preparing grant applications, through experimental planning, to the analysis and interpretation of experimental results, the company said.
"Our customers have been using Pathway Studio in different fields: RNAi, target and biomarker discovery, disease mechanism research, and many others to organize published information and use it to supplement experimental work and validate hypotheses", World Fusion President Kozo Kawahara said in a statement.
Ariadne President Ilya Mazo said that the company has been using World Fusion to market its products to biotechnology and pharmaceutical companies for more than four years.
Now, Mazo added, “we expect World Fusion will expand the academic market and will be successful as exclusive distributor.”